Frontlight ResearchEarly access
Alzheimer disease trials in China
51 of 134 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in ChinaChinese University-Alzheimer's Disease With Vascular and Other Co-pathology: Towards Actionable Neuro-Cognitive-Omic Evaluations (CU-ADVANCE)
- Where
- Hong Kong
- Age
- 40 years and over
- People
- 1,600
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07917182 - No phaseTaking peopleCommunity-based Screening for Alzheimer's Disease
- Where
- Shanghai
- Age
- 60 years to 80 years
- People
- 3,000
- Run by
- Kuang XiaoJun
See details and how to joinNCT07570719 - No phaseTaking peopleEffectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
- Where
- Shanghai
- Age
- 18 years and over
- People
- 3,000
- Run by
- Fudan University
See details and how to joinNCT07923812 - No phaseTaking peopleChina HEalthy Aging and Dementia Study (HEAD)
- Where
- Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hefei, Jinan, Nanjing, Qingdao, Shanghai, Shenzhen, Taizhou, Tianjin, Wuhan, Xiamen, Xining, Zhoukou
- Age
- 18 years and over
- People
- 20,000
- Run by
- Fudan University
See details and how to joinNCT07912710 - No phaseTaking peopleFuzhou Aging Brain Health Initiative
- Where
- Fushun, Fuzhou
- Age
- 55 years to 90 years
- People
- 3,000
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07891429 - No phaseTaking peopleStudy on Clinical Characteristics of Patients With Probable Alzheimer's Dementia Stratified by Blood Biomarkers
- Where
- Tianjin
- Age
- 55 years to 90 years
- People
- 200
- Run by
- Tianjin Anding Hospital
See details and how to joinNCT07875998 - No phaseTaking peopleA Prospective Cohort Study of Multimodal Biomarkers and Progression From Mild Cognitive Impairment to Dementia
- Where
- Beijing
- Age
- 50 years and over
- People
- 600
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT07876570 - No phaseTaking peopleMultimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
- Where
- Beijing
- Age
- 50 years and over
- People
- 200
- Run by
- Peking University First Hospital
See details and how to joinNCT06924359 - No phaseNot yet taking people in ChinaCognition and Affective Research in China
- Where
- Beijing
- People
- 3,000
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT07833267 - No phaseTaking people[18F]NIDF PET Imaging in Tau-related Diseases
- Where
- Hefei, Qingdao, Tianjin
- Age
- 18 years to 90 years
- People
- 20
- Run by
- Tianjin Medical University
See details and how to joinNCT07306598 - No phaseTaking peopleThe Effect of Sequential Therapy on Alzheimer's Disease
- Where
- Beijing
- Age
- 55 years to 85 years
- People
- 600
- Run by
- Dongzhimen Hospital, Beijing
See details and how to joinNCT07768579 - No phaseTaking peopleAn Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
- Where
- Hangzhou
- Age
- 45 years to 85 years
- People
- 400
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07153848 - No phaseTaking peopleNeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK
- Where
- Hong Kong
- Age
- 60 years to 75 years
- People
- 2,500
- Run by
- Hong Kong University of Science and Technology
See details and how to joinNCT07347574 - No phaseTaking peopleClinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression
- Where
- Nanchang
- Age
- 50 years and over
- People
- 44
- Run by
- Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07676851 - No phaseTaking peopleStudy on the Health Economic Burden of Alzheimer's Disease in China
- Where
- Beijing
- Age
- 40 years to 100 years
- People
- 9,510
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT05995418 - No phaseEnrolling by invitationChina-NINE Cohort:Neuroimmune Network in Elderly / Neurodegeneration
- Where
- Yantai
- Age
- 55 years to 75 years
- People
- 260
- Run by
- Yantai Yuhuangding Hospital
See details and how to joinNCT07586501 - No phaseNot yet taking people in ChinaEfficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice
- Where
- Hangzhou
- Age
- 50 years to 85 years
- People
- 140
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07505095 - No phaseTaking peopleChina Cognition and Aging Study
- Where
- Anshan, Baotou, Changchun, Changping, Chaoyang, Dalian, Fengtai, Fujian, Guangzhou, Guiyang, Haerbin, Haidian, Handan, Hangzhou, Hefei, Huangpu, Jinan, Jining, Kaifeng, Luwan, Nanchang, Nanchong, Nanning, Nantong, Ningbo, Putong, Qingdao, Shenyang, Shijiazhuang, Subei, Tai’an, Taiyuan, Tangshan, Ürümqi, Wenzhou, Wuhan, Xi’an, Xianshuigu, Xiaobailou, Xicheng, Xuzhou, Yinchuan, Yuzhong, Zhengzhou, Zhijiazhuang, Zhongshan, Zigong
- Age
- 18 years and over
- People
- 100,000
- Run by
- Capital Medical University
See details and how to joinNCT03653156 - No phaseTaking peopleThe Chinese Familial Alzheimer's Network
- Where
- Anshan, Baotou, Changchun, Changping, Chaoyang, Dalian, Fengtai, Fujian, Guangzhou, Guiyang, Haerbin, Haidian, Handan, Hangzhou, Hefei, Huangpu, Jinan, Jining, Kaifeng, Luwan, Nanchang, Nanchong, Nanning, Nantong, Ningbo, Putong, Qingdao, Shenyang, Shijiazhuang, Subei, Tai’an, Taiyuan, Tangshan, Ürümqi, Wenzhou, Wuhan, Xi’an, Xianshuigu, Xiaobailou, Xicheng, Xuzhou, Yinchuan, Yuzhong, Zhengzhou, Zhijiazhuang, Zhongshan, Zigong
- Age
- 18 years and over
- People
- 40,000
- Run by
- Capital Medical University
See details and how to joinNCT03657732 - No phaseTaking peopleStudy on Biomarkers for Early Diagnosis of Alzheimer's Disease
- Where
- Beijing
- Age
- 18 years and over
- People
- 6,000
- Run by
- Capital Medical University
See details and how to joinNCT04575337 - No phaseTaking peopleDetection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
- Where
- Beijing
- Age
- 55 years to 75 years
- People
- 1,500
- Run by
- Capital Medical University
See details and how to joinNCT04850053 - No phaseTaking peopleThe Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease
- Where
- Beijing
- Age
- 55 years to 75 years
- People
- 3,200
- Run by
- Capital Medical University
See details and how to joinNCT05020106 - No phaseNot yet taking people in ChinaDigital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification Theory: an Integrated Study
- Where
- Shenyang
- Age
- 50 years and over
- People
- 1,000
- Run by
- First Hospital of China Medical University
See details and how to joinNCT07286812 - No phaseTaking peopleProspective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab
- Where
- Hangzhou
- Age
- Up to 85 years
- People
- 120
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06741553 - No phaseTaking peopleEnvironmental Pollutants and Neurological Disorders
- Where
- Beijing
- Age
- 18 years and over
- People
- 500
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07140601